Delayed Allograft Rejection by the Suppression of Class II Transactivator

Experimental & Molecular Medicine
doi 10.1038/emm.2006.26
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cutting Edge: Activation of HIV-1 Transcription by the MHC Class II Transactivator

Journal of Immunology
AllergyImmunology
2000English

Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II Expression

Immunity
Infectious DiseasesAllergyImmunology
1996English

Mitogen-Activated Protein Kinase ERK1/2 Regulates the Class II Transactivator

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Novel Mutation in the Class II Transactivator Associated With Immunodeficiency and Autoimmunity

Journal of Clinical Immunology
AllergyImmunology
2015English

The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease

Journal of Immunology
AllergyImmunology
2002English

MHC Class II Transactivator (CIITA) Expression Is Upregulated in Multiple Myeloma Cells by IFN-γ

Molecular Immunology
ImmunologyMolecular Biology
2007English

Suppression of Tissue Graft Rejection by Spergualin.

Journal of Antibiotics
Drug DiscoveryPharmacology
1985English

Antibody-Mediated Kidney Allograft Rejection

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy